C. diff. Spores and More

Join us with guest Sarah Mische, PhD as we discuss the value and importance of Clinical Trials worldwide. Learn about the different phases, the efficacy, patient safety, and research and development that begins the process. Clinical Trials have a beginning, evaluations, FDA meetings, with time well spent by dedicated Science professionals, Clinicians, Health care Providers, and the individuals who are accepted to participate in the studies. It will be an episode you won't want to miss! Listen in and learn how we can help them - to help you - to help others.

Join us with our guest Carolyn Twomey, BSN, RN as we discuss infection prevention, and antibiotic stewardship in health care settings.

Join us with our guest Carolyn Twomey, BSN, RN as we discuss infection prevention, and antibiotic stewardship in health care settings.

Join us with our guest, Maureen Spencer, RN, M.Ed., board certified in infection control (CIC) for over 30 years and currently the Director, Clinical Implementation at Accelerate Diagnostics, providing educational and consultative services to the sales and marketing teams in the U.S.. Maureen will be discussing why C.difficile infections is a significant infection in healthcare, the role of the Infection Preventionist and the importance of infection surveillance and testing in healthcare. Listen in as Maureen shares the key-points in preventing the spread of infections -- especially a C. difficile infection.

Join us with our guest, Maureen Spencer, RN, M.Ed., board certified in infection control (CIC) for over 30 years and currently the Director, Clinical Implementation at Accelerate Diagnostics, providing educational and consultative services to the sales and marketing teams in the U.S.. Maureen will be discussing why C.difficile infections is a significant infection in healthcare, the role of the Infection Preventionist and the importance of infection surveillance and testing in healthcare. Listen in as Maureen shares the key-points in preventing the spread of infections -- especially a C. difficile infection.

Join us with guest Kevin Hersh, Int'l Life Coach as we discuss lifestyle methods to cope with Seasonal Affective Disorder. What is Seasonal Affective Disorder (SAD)? Seasonal Affective Disorder (SAD) is commonly referred to as the winter blues or winter depression. People typically experience it starting in the fall and all through winter. Sunny summer days and warm weather can improve your mood, so it makes sense that the time change combined with cooler weather and shorter days can have impact mental health. Seasonal Affective Disorder is recognized as a type of depression and can cause increased anxiety, sadness and stress, lack of enjoyment in regular activities, feelings of isolation, mood swings, and several other symptoms that can take over your life. There are ways to help deal with it, so gather your notebook and electronic devices to takes notes as we discuss ways to cope with Seasonal Affective Disorder(SAD).

Join us as Dr. Dale Gerding, MD, an Infectious Disease specialist, researcher, professor, hospital epidemiologist, and one of the leading international experts on Clostridium diffiicle (C.diff.), will discuss his patented non-toxigenic Clostridium difficile (NTCD-M3) technology for the prevention and treatment of a C. diff. infection. Dr.Gerding currently owns patents and all rights to the development, manufacturing, regulatory, and clinical trial data for NTCD-M3. The lead pharmaceutical product, NTCD-M3, incorporating this technology has already completed Phase 1 & 2 Clinical Trials, has FDA Fast Track approval, is expected to be eligible for Breakthrough Therapy Designation by the FDA for a Phase 3 Clinical Trial, and to be eligible for Reference Product Exclusivity for 12 years for an approved biologics license application.

Join us with our guest, Stuart Johnson, MD as we discuss, 'What is C.difficile?', how a C.diff. infection CDI can be prevented, Vancomycin - the preferred treatment available today and being utilized to treat this infection and much more.

Join us with our two guests: Brad Lucus and Hanson Meyer of Hygeia as they discuss a novel approach to killing C. difficile (C;diff.) using electrochemistry instead of conventional chemistry in cleaning and sanitizing. The benefits of electrochemistry to cleaning and the limitations of electrochemistry will be discussed. We will also talk about the safety advantages of using electrochemistry and where it is currently being used today to combat germs. We will discuss recent studies from Europe and America regarding the limitations of conventional chemistry in cleaning and the growing use of electrochemistry.

Our guests Nancy Foster, Vice President, Quality and Patient Safety Policy, American Hospital Association and Edmond A. Hooker, MD, DrPH will be discussing the Centers for Medicare and Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services, CMS 2019 Inpatient Prospective Payment System (IPPS) proposed rule – which includes proposals to de-duplicate measures across the five hospital quality reporting programs.

This special live broadcast discussion will be about the CMS’ recent proposals for Healthcare-associated infection (HAI) measures and to provide facts that will bring forth a better understanding of the proposed rule.